• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconVaccines

Vaccines

Page 22 of 32
How vaccine nationalism could extend the pandemic
Health
How vaccine nationalism could extend the pandemic
By James Paton and BloombergJanuary 31, 2021
COVID vaccine rollout problems
Health
What we know about the 5 biggest problems with the COVID vaccine rollout
By Sy MukherjeeJanuary 31, 2021
Tom Richmond receives his AstraZeneca/Oxford University Covid-19 vaccine from Vaccinator Louise Chadwick at Acklam Road pharmacy on January 28, 2021 in Middlesbrough, England.
Health
With supplies running low, Europe approves AstraZeneca’s COVID-19 vaccine for all adults
By Jeremy Kahn and David MeyerJanuary 29, 2021
Pascal Soriot, chief executive officer of AstraZeneca Plc, listens during a Senate Finance Committee hearing on drug pricing on Capitol Hill in Washington, D.C., U.S., on Tuesday, Feb. 26, 2019.
Health
Germany may not use AstraZeneca’s vaccine for over-65s, as experts debate lack of data
By Jeremy Kahn and David MeyerJanuary 28, 2021
Valneva-Covid19 Vaccine
Health
France’s Valneva starts making COVID-19 vaccine in Scotland, ahead of trial results and approval
By David MeyerJanuary 28, 2021
An NHS staff member prepares an AstraZeneca Covid-19 vaccination as over-eighty year olds receive their vaccinations on January 26, 2021 at Stithians Showground, near Truro, England.
Health
Furious at AstraZeneca, the EU plans export controls for COVID vaccines made on its home turf
By David MeyerJanuary 26, 2021
Pharmacist Josh Athwal (left) receives an injection of the Oxford/Astrazeneca coronavirus vaccine, administered by nurse Gurit Dhadday, at The Black Country Living Museum in Dudley.
Health
AstraZeneca is finding it hard to keep its COVID-19 vaccine promises
By David MeyerJanuary 25, 2021
Good news: COVID-19 vaccine skepticism is waning. Bad news: That might not be enough
Health
Good news: COVID-19 vaccine skepticism is waning. Bad news: That might not be enough
By Bernhard Warner and David MeyerJanuary 22, 2021
Why the COVID vaccine rollout is a massive tech challenge
Tech
Why the COVID vaccine rollout is a massive tech challenge
By Fortune EditorsJanuary 22, 2021
How to accelerate the far-too-slow COVID vaccine rollout
Commentary
How to accelerate the far-too-slow COVID vaccine rollout
By Oliver KharrazJanuary 21, 2021
David A. Kessler COVID
Health
Meet the man tasked with fixing America’s bungled COVID vaccine rollout
By Sy MukherjeeJanuary 20, 2021
A man wearing a mask removing a tray of vaccine doses from an ultra-low temperature refrigerator.
Health
A British hospital network is using blockchain technology to track COVID-19 vaccines
By Jeremy KahnJanuary 19, 2021
No direct link between the COVID vaccine and a recent string of deaths in the elderly, Norway finds
Health
No direct link between the COVID vaccine and a recent string of deaths in the elderly, Norway finds
By Lars Erik Taraldsen and BloombergJanuary 18, 2021
Public health officials warn about slow vaccine rollout as coronavirus variants multiply
Health
Public health officials warn about slow vaccine rollout as coronavirus variants multiply
By James Paton and BloombergJanuary 18, 2021
A photo of Jonas Salk injecting a boy with the polio vaccine he invented.
Health
The COVID-19 vaccination drive may be slow—but it’s already faster than any in history
By Jeremy KahnJanuary 17, 2021
1...
  • 20
  • 21
  • 22
  • 23
  • 24
...32
Most Popular
Arts & Entertainment
Ed Sheeran asked Patriots owner Robert Kraft for $2 million aid donation after Macklemore was dropped from his tour for pro-Palestine commentsplaceholder alt text
By Marco Quiroz-GutierrezSeptember 18, 2026
Success
Anthropic billionaire cofounder Jack Clark studied literature, not code—and says liberal arts degrees will win in the AI ageplaceholder alt text
By Marco Quiroz-GutierrezSeptember 19, 2026
Economy
Treasury yields are already blowing up the CBO’s long-term forecasts, and experts who previously downplayed U.S. debt fears are now starting to worryplaceholder alt text
By Jason MaSeptember 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.